CXCL8 and neoplasm: At necropsy, the TRAF3IP2KD shRNA-LV treated mice showed a small residual tumor (Fig. 6C), which upon analysis revealed a marked reduction in IL-8, CytokeratinAE1/AE3 and Ki67 expression (Fig. 6D).